Belviq articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/24 12:19
2013/05/24 12:19
1d
Novo obesity drug could launch in U.S. end 2014
COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the...
1
RELATED
Novo Nordisk Copenhagen Deutsche Bank Reuters Soren Hansen
MENTIONED
2013/05/24 12:19
2013/05/24 12:19
Latest videos
2013/05/24 12:19
2013/05/24 12:19
Latest from Twitter
2013/05/23 20:06
2013/05/23 20:06
1d
Weight-loss pill cleared for sales
WASHINGTON — Arena Pharmaceuticals' Belviq, the weight-loss pill approved in June by the Food and Drug Administration, was cleared to start sales next month after a separate review found the drug's...
Drug Enforcement Administration Food and Drug Administration Washington San Diego Bloomberg Industries
MENTIONED
2013/05/08 12:27
2013/05/08 12:27
17d
Free Research Reports on AMRI, ARNA, MKTG and SCT...
NEW YORK, NY--(Marketwired - May 8, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential...
29
RELATED
NEW YORK Providence Media Strategies LLC MBIA Inc. YRC Worldwide Inc. Entergy Corporation
MENTIONED
2013/05/03 07:29
2013/05/03 07:29
22d
Top After-Market NASDAQ Movers (Procera Networks,...
FormFactor Inc. (NASDAQ:FORM) shares surged 7.14 percent to $5.10 in post-market trading after losing more than 4 percent in regular trading on Thursday. Equities researchers at Needham & Company...
Needham & Company European Union European Medicines Agency
MENTIONED
2013/05/02 22:06
2013/05/02 22:06
22d
Arena Withdrawing Obesity Drug Regulatory Applica...
Arena will review its application to the European Medicines Union for Belviq, approved in the U.S. in June as the first new obesity drug in 13 years, before deciding when to resubmit it, the San...
San Diego Tokyo Drug Enforcement Administration NEW YORK FDA
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.